Finance

Lists
GLUE:NASDAQ
Monte Rosa Therapeutics Inc
10,63 $
0,00%
(0,00) 1D
10,65 $
+0,19% (+0,020)
Pre-market
Closed: 2 նոյ, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLUE...
Mkt. cap
906,88 մլն
Avg. vol.
1,46 մլն
Volume
2,72 հզր
52-wk high
25,77 $
52-wk low
9,68 $
EPS
-1,74 $
Beta
1,41
Shares outstanding
85,31 մլն
No. of employees
173
Mkt. cap
906,88 մլն
Avg. vol.
1,46 մլն
Volume
2,72 հզր
52-wk high
25,77 $
52-wk low
9,68 $
EPS
-1,74 $
Beta
1,41
Shares outstanding
85,31 մլն
No. of employees
173
News stories
From web sources and news partners
About Monte Rosa Therapeutics Inc
CEO-
Employees173
Founded2019
HeadquartersԲոստոն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitemonterosatx.com
Analyst ratings
Based on 7 analysts giving stock ratings to GLUE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for GLUE in the last 3 months.
Highest
Current 10,63 $
37,00 $ (+248,07%)
Average
27,17 $ (+155,60%)
Lowest
19,00 $ (+78,74%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
UBS
Buy
Reiterated
19,00 $
+78,7%
10/12/2026
Alice Nettleton
UBS
Buy
Initiated
19,00 $
+78,7%
10/12/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
25,00 $
+135,2%
10/05/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
-
-
10/02/2026
Robert Driscoll
Wedbush
Buy
Maintained
27,00 $
+154%
10/02/2026
Unknown Analyst
Wedbush
Buy
Maintained
27,00 $
+154%
10/02/2026
Michael Schmidt
Guggenheim
Buy
Maintained
28,00 $
+163,4%
10/01/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
37,00 $
+248,1%
10/02/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
27,00 $
+154%
08/10/2026
Faisal Khurshid
Jefferies
Buy
Maintained
25,00 $
+135,2%
07/31/2026
Derek Archila
Wells Fargo
Buy
Reiterated
29,00 $
+172,8%
06/24/2026
Marc Frahm
TD Cowen
Buy
Reiterated
-
-
05/07/2026
Next call 10 օրից
նոյ 13, ուր, 16:30
Fiscal period
Q3 2026
- / -0,20 $
Revenue / Est. (USD)
- / 33,89 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
12,77 մլն
2,78 մլն
4,21 մլն
8,97 մլն
Cost of goods sold
34,65 մլն
39,89 մլն
41,82 մլն
45,99 մլն
Cost of revenue
34,65 մլն
39,89 մլն
41,82 մլն
45,99 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,09 մլն
12,60 մլն
12,42 մլն
12,11 մլն
Operating expense
11,09 մլն
12,60 մլն
12,42 մլն
12,11 մլն
Total operating expenses
45,74 մլն
52,50 մլն
54,24 մլն
58,10 մլն
Operating income
-32,98 մլն
-49,72 մլն
-50,03 մլն
-49,13 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-30,26 մլն
-46,08 մլն
-44,45 մլն
-43,19 մլն
EBT excluding unusual items
-30,26 մլն
-46,08 մլն
-44,45 մլն
-43,19 մլն
Income tax expense
-3,18 մլն
59,00 հզր
52,00 հզր
208,00 հզր
Effective tax rate
10,50%
-0,13%
-0,12%
-0,48%
Other operating expenses
-
-
-
-
Net income
-27,08 մլն
-46,14 մլն
-44,50 մլն
-43,40 մլն
Net profit margin
-212,10%
-1 658,94%
-1 057,08%
-483,91%
Earnings per share
-0,33
-0,55
-0,45
-0,43
Interest and investment income
2,75 մլն
3,69 մլն
5,59 մլն
5,92 մլն
Interest expense
-
-
-
-
Net interest expenses
2,75 մլն
3,69 մլն
5,59 մլն
5,92 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,88 մլն
-47,63 մլն
-48,00 մլն
-47,22 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps